Sofosbuvir Plus Ledipasvir for Recurrent Hepatitis C in Liver Transplant Recipients

Liver Transplantation - United States
doi 10.1002/lt.24724
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Wiley

Related search

Ledipasvir and Sofosbuvir for Recurrent Hepatitis C After Liver Transplantation

BioScience Trends
BiochemistryHealthMedicineGeneticsMolecular Biology
2016English

Sofosbuvir/Ledipasvir and Ribavirin Tolerability and Efficacy in Pediatric Liver Transplant Recipients

Liver Transplantation
HepatologyTransplantationSurgery
2017English

Kidney Transplant Recipients With Hepatitis C Virus Experienced 100% SVR12 Rate When Treated With Sofosbuvir-Ledipasvir

Hepatology
MedicineHepatology
2017English

Hepatitis C Virus Genotypes in Liver Transplant Recipients

Transplantation
Transplantation
1997English

Cost Effectiveness Analysis of Sofosbuvir and Ledipasvir/Sofosbuvir in Hepatitis C Virus (HCV) Patients

Value in Health
MedicineHealth PolicyPublic HealthOccupational HealthEnvironmental
2016English

Hepatitis C Viremic Donors for Hepatitis C Negative Liver Transplant Recipients: Ready for Prime Time?

Liver Transplantation
HepatologyTransplantationSurgery
2017English

The Use of Sofosbuvir for the Treatment of Recurrent Hepatitis C After Liver Transplantation

Transplantologiya
2017English

Ledipasvir/Sofosbuvir Effectively Treats Hepatitis C Virus Infections in an Underserved Population

Digestive Diseases and Sciences
PhysiologyGastroenterology
2018English

Efficacy and Safety of Ribavirin With Sofosbuvir Plus Ledipasvir in Patients With Genotype 1 Hepatitis C: A Meta-Analysis

Digestive Diseases and Sciences
PhysiologyGastroenterology
2016English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy